Specialties & Topics
- Arthritis/Rheumatic Disease
- Breast Cancer
- GERD/Peptic Ulcers
September 12th, 2009
Podcast 56: A conversation with two JAMA staffers on their research into “ghost” authorship and “honorary” authorship in the principal medical journals.
(2 votes, average: 4.50 out of 5)
We’ve seen research into this area before — 18 months ago, in fact. (We interviewed Joseph Ross back then in Podcast #2.) This time we interview Joseph Wislar, a survey-research specialist at JAMA, and Annette Flanagin, its managing deputy editor. They’ve just presented the abstracted results of a survey on ghost and honorary authorship that encompasses hundreds of articles from the principal medical journals.
If you would like to comment, give us a call and leave a message at 1-617-440-4374 or drop me a note at email@example.com.
This week’s links:
- Barack Obama speech transcript
- H1N1 Update: Early Results on Vaccine Indicate One Dose May Be Sufficient for Most Groups
- FDA Advisers: HPV Vaccine Should Be Approved for Use in Boys, Young Men
- New York Times story on “ghostwriting” in the principal medical journals
- Link to last year’s interview with Joseph Ross
- Physician’s First Watch coverage
About the Podcast
To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.
- Podcast 184: Ruling out pulmonary embolism in primary care
- Podcast 185: A Spirited Discussion on Medicare’s ‘Doc Fix’ Fix for Reimbursement
- Podcast 183: An Obesity ‘Switch’ in the Genome Described
- Podcast 182: Dietary fat studies meta-analyzed — trans fat still a bad bet
- Podcast 179: Pradaxa (dabigatran) reversal near?
- Podcast 126: Placebos and Medical ‘Meaning’ (4)
- Podcast 149: High levels of white rice consumption seem linked to higher risks for type 2 diabetes (3)
- Podcast 111: A look back on the year’s most clinically important developments. (3)
- Podcast 160: The Marathon bombing — lessons learned (2)
- Podcast 136: Aspirin lowers colorectal risks in Lynch syndrome — what are the implications for everyone else? (2)
- Less Bleeding with Rivaroxaban for Venous Thromboembolism
- Patients with Allergies to One Cephalosporin Often Can Tolerate Others
- Reaffirming the Role of LTRAs as an Alternate Therapy for Asthma
- Bioavailable (Free) 25-Hydroxyvitamin D Levels in Black and White Americans
- Lower Rate of Adverse Cardiovascular Events with the Diabetes Drug Empagliflozin
Physician's First WatchToday's breaking medical news
- 2009 H1N1 acute coronary syndromes antidepressants aspirin asthma breast cancer cancer risk cardiovascular disease Cardiovascular risk clopidogrel COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients PPI pregnancy Prostate cancer proton pump inhibitors Quality of care risk rosiglitazone screening smoking statins stents stroke vaccination warfarin